Stockscreener 앱 받기
26.42
2.15%
-0.58
시간 외 거래:
26.80
0.38
+1.44%
Grail Inc 주식(GRAL)의 최신 뉴스
This Cancer Test Could Become Routine—and a Big Seller, Says Analyst - Barron's
Canaccord sets $32 target on GRAIL stock with buy rating By Investing.com - Investing.com Nigeria
Canaccord starts Grail with a Buy, sees ‘solid upside’ - TipRanks
Canaccord Genuity Initiates GRAIL at Buy With $32 Price Target - marketscreener.com
Canaccord sets $32 target on GRAIL stock with buy rating - Investing.com Australia
GRAIL, Inc. (GRAL): A Bull Case Theory - Insider Monkey
Form DEF 14A GRAIL, Inc. For: May 29 - StreetInsider
GRAIL's Galleri Progresses While Back In Accumulation Levels - Seeking Alpha
AI-Powered Studio GRAiL Launched By Davide Bianca & Jeff Krelitz - Deadline
How Does GRAIL Benefit From The Proposed MCED Legislation? (NASDAQ:GRAL) - Seeking Alpha
Multi-Cancer Early Detection Market Critical Analysis with Expert Opinion| GRAIL, Natera, Elypta - openPR.com
Jim Cramer Likes GRAIL, Inc. (GRAL) Despite Losses – Great Science, Risky Bet! - Yahoo Finance
Illumina to buy Jeff Bezos-backed cancer testing firm Grail in $8 billion deal - MarketScreener
A Sydney company’s laser focus on energy’s holy grail - @AuManufacturing
Opinion | One ‘Monopoly’ That Could Save Your Life - The Wall Street Journal
Is GRAIL Stock About to Skyrocket? - timothysykes.com
GRAIL Careers, Perks + Culture - Built In
Debate Over Multi-Cancer Screening Tests Shifts Pending Grail Randomized Trial Results - GenomeWeb
FDA approval remains Holy Grail for Aussie biotechs - NT News
Biocurious: FDA approval remains the Holy Grail for ASX life science stocks - Stockhead
Grail price target raised to $20 from $16 at Morgan Stanley - TipRanks
Have Insiders Sold GRAIL Shares Recently? - Simply Wall St
Jim Cramer On Netflix, Inc. (NFLX) – Subscription Is the Holy Grail—Netflix Is Doing Very Well! - Insider Monkey
Illumina Wins Court Fight With EU Over $7 Billion Grail Deal - MSN
Grail president Joshua Ofman sells $65,800 in common stock By Investing.com - Investing.com Australia
Grail CEO Robert Ragusa sells $237,976 in stock By Investing.com - Investing.com Canada
Grail CEO Robert Ragusa sells $237,976 in stock - Investing.com India
Grail president Joshua Ofman sells $65,800 in common stock - Investing.com
Oppenheimer & Co. Inc. Invests $190,000 in Grail, Inc. (NASDAQ:GRAL) - Defense World
Rhumbline Advisers Makes New Investment in Grail, Inc. (NASDAQ:GRAL) - Defense World
New York State Common Retirement Fund Makes New $59,000 Investment in Grail, Inc. (NASDAQ:GRAL) - Defense World
Grail’s Stock Surge: An Eye on Future Moves - timothysykes.com
GRALGrail Inc Latest Stock News & Market Updates - StockTitan
Is GRAIL, Inc. (GRAL) Among Jeff Bezos’ Investments in 2025? - Yahoo Finance
Jeff Bezos Investments in 2025: 12 Companies Bezos Is Investing In - Insider Monkey
Ieq Capital LLC Acquires Shares of 19,874 Grail, Inc. (NASDAQ:GRAL) - MarketBeat
Grail (NASDAQ:GRAL) Trading 9.8% HigherWhat's Next? - MarketBeat
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - PR Newswire
Grail goes ‘Grey’s’: Actor Kate Walsh joins awareness campaign for multi-cancer early detection testing - FiercePharma
GRAIL Partners With Actress Kate Walsh for Generation Possible to Raise Awareness of Multi-Cancer Early Detection Testing - Longview News-Journal
Grail projects FDA submission completion for Galleri by H1 2026 with expanded scalability - MSN
GRAIL, Inc. (GRAL): Among the Best Performing Small Cap Stocks So Far In 2025 - Insider Monkey
Why Grail (GRAL) Is Falling Today - MSN
Van ECK Associates Corp Takes $475,000 Position in Grail, Inc. (NASDAQ:GRAL) - Defense World
Grail initiated at equal weight by Morgan Stanley - MSN
Can GRAIL's Cancer Detection Technology Transform Healthcare? Key Presentation Coming March 4 - StockTitan
Putting early cancer detection to the test - Nature.com
GRAIL Q4 Loss Narrows, Revenue Up; Shares Rise After-Hours - MarketScreener
Earnings call transcript: Grail’s Q4 2024 revenue rises, stock surges - Investing.com
1.18%
자본화:
|
볼륨(24시간):